Scienture Holdings, Inc. (Nasdaq: SCNX) disclosed entering a securities purchase agreement with institutional investors for a direct offering of 3,225,000 shares of common stock.
The offering price is set at $1.20 per share, aiming to raise approximately $3.9 million in gross proceeds.
Maxim Group LLC is the sole placement agent for this offering.
Offering Details
3,225,000 shares of common stock to be sold at $1.20 per share, expecting to generate $3.9 million.
Placement Agent
Maxim Group LLC serves as the sole placement agent in the direct offering.
Registration Statement
Offering made under an effective shelf registration statement on Form S-3, filed with the SEC on August 1, 2025.
- The offering is expected to enhance the Company's financial position through the infusion of approximately $3.9 million in gross proceeds.
- This move reflects Scienture's proactive approach in securing funds for its ongoing operations and strategic initiatives.
The successful completion of the direct offering showcases investor confidence in Scienture Holdings, Inc.'s growth prospects and underscores its commitment to bolstering its pharmaceutical offerings.